Key Highlights

  • Q2 2026 revenue before reimbursables rose 15.7% to $465.6 million.
  • Net income climbed 60.8% to $31.2 million.
  • The company completed the RelateCare acquisition during the quarter.
  • Full-year adjusted EPS guidance was raised to $9.00 to $9.40.

Huron Consulting Group (NASDAQ:HURN) has moved into focus after raising its full-year 2026 outlook alongside a second-quarter report that showed double-digit organic growth across its consulting franchise. The professional services firm, which advises hospitals, universities and commercial clients, reported higher revenue, sharply higher net income and an increased share repurchase tally. For investors tracking mid-sized professional services names, the combination of faster growth, a larger balance sheet commitment to buybacks and a freshly acquired managed-services business raises a practical question: how much of the improvement could prove durable through the remainder of the year?

Latest Company Context

In results for the quarter ended June 30, 2026, Huron reported revenues before reimbursable expenses of about $465.6 million, up 15.7% from a year earlier, with organic growth of 10.8%. Net income rose 60.8% to $31.2 million, or $1.91 per diluted share, while adjusted diluted earnings per share, a non-GAAP measure, came in at $2.46. Adjusted EBITDA was $72.6 million, equal to 15.6% of revenue before reimbursables. The company also completed the acquisition of RelateCare during the quarter, adding roughly 1,100 managed-services professionals. Management raised full-year guidance to revenue before reimbursables of $1.85 billion to $1.89 billion and adjusted diluted EPS of $9.00 to $9.40. Year to date, revenue before reimbursables reached about $909.3 million, up 13.9%, with adjusted diluted EPS of $4.16.

Key Business and Index Drivers

Segment results show where the momentum is coming from. Healthcare revenue before reimbursables rose 17.4% to about $232.3 million, Commercial grew 24.6% to roughly $94.0 million, and Education advanced 7.8% to about $139.4 million. Healthcare remains the largest contributor, so demand from provider organizations is central to the story. Guidance also calls for adjusted EBITDA of 14.5% to 15.0% of revenue before reimbursables for the year, implying that margin expansion, not just top-line growth, is part of management's plan. Hitting that range would require the second half to sustain the quarter's profitability, which is a projection rather than a result. Capital allocation is the other driver: Huron repurchased about $53.1 million of stock in the second quarter and $208.6 million year to date, while long-term debt net of the current portion stood at about $812.8 million at quarter-end.

What Investors Should Watch

Several items could shape sentiment in coming months. The first is whether organic growth holds near the double-digit pace as the company laps tougher comparisons in the second half. The second is integration of RelateCare and whether managed services contribute to margins as management intends. Investors may also monitor leverage, given borrowings used to fund acquisitions and buybacks, and how interest costs affect adjusted earnings. Finally, the next quarterly report, expected after the close of the third quarter, will show whether Huron is tracking within its raised ranges. Any change in client spending on healthcare operations or higher education technology could also influence the outlook.

Momentum Across Every Segment

Huron's latest report offers a clear set of confirmed facts: faster revenue growth, higher profit, a raised outlook and continued repurchases. What remains uncertain is how much of that performance can be sustained if healthcare and education budgets tighten, or if acquisition integration proves slower than planned. The guidance ranges are management projections, not outcomes, and may change. For readers, the most useful approach could be to follow upcoming filings, segment trends and margin delivery rather than rely on any single quarter.